文献速递医学人工智能与信息学基础与转化研究

基于多模态数据的人工智能痴呆病因鉴别诊断

AI-based differential diagnosis of dementia etiologies on multimodal data.
PubMed 文献 · Nat Med · 2024-07-04

该研究利用涵盖人口学、病史、用药、神经心理评估、功能评估和多模态神经影像等多维度数据的人工智能模型,在9个独立地理多样性数据集的51269名参与者中识别10种痴呆病因,模型在正常认知、轻度认知障碍和痴呆分类中微平均AUROC为0.94,鉴别痴呆病因微平均AUROC为0.96,在100例随机子集中神经科医生评估结合AI模型后AUROC较仅神经科医生评估提高26.25%。

要点

  • AI模型在9个数据集51269名参与者中识别10种痴呆病因,病因鉴别微平均AUROC为0.96。
  • 模型对两种共存病理的混合痴呆平均AUROC为0.78。
  • 100例随机子集中,神经科医生评估结合AI模型后AUROC较仅神经科医生评估提高26.25%。

核心结论

  • 该框架有潜力作为临床环境和药物试验中的痴呆筛查工具,但需进一步前瞻性研究确认其改善患者管理的能力。

研究设计与样本

  • 研究基于9个独立、地理多样性的数据集,共纳入51269名参与者,利用人工智能模型整合人口学、个人及家族病史、用药、神经心理评估、功能评估和多模态神经影像等数据。

主要发现

  • 模型在分类正常认知、轻度认知障碍和痴呆个体时微平均AUROC为0.94。
  • 模型在鉴别痴呆病因时微平均AUROC为0.96。
  • 模型在两种共存病理的混合痴呆病例中平均AUROC为0.78。
  • 在随机选取的100例子集中,神经科医生评估结合AI模型后的AUROC较仅神经科医生评估提高26.25%。
  • 模型预测与生物标志物证据一致,其与不同蛋白质病的关联经尸检发现证实。

临床怎么用

  • 作者认为该框架有潜力作为临床环境和药物试验中的痴呆筛查工具,但需进一步前瞻性研究确认其改善患者管理的能力。

局限性

  • 需进一步前瞻性研究确认其改善患者管理的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an artificial intelligence (AI) model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a microaveraged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the microaveraged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in clinical settings and drug trials. Further prospective studies are needed to confirm its ability to improve patient care.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Xue C, Kowshik SS, Lteif D, et al. AI-based differential diagnosis of dementia etiologies on multimodal data. Nat Med. 2024. PMID: 38965435. doi:10.1038/s41591-024-03118-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。